Evidence map›Paper›PMID 30571326›Full record

ArticleCirculation. Cardiovascular imaging2018

Dual-Contrast

Gregory M Lanza

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation. Cardiovascular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Gregory M LanzaDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.

Funding

Project 2 - Radiation-Induced Treatment of Multiple Myeloma using NanoparticlesU54CA199092 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2015 to 2019
$11.5M
OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPYR01CA216840 · NCI · WASHINGTON UNIVERSITY · PI LANZA, GREGORY M, WEILBAECHER, KATHERINE NELSON · 2018 to 2022
$3.1M
Fibrin-Specific Thrombolytic Nanoparticles for Acute StrokeR01NS059302 · NINDS · WASHINGTON UNIVERSITY · PI LANZA, GREGORY M · 2007 to 2011
$1.7M
Development of Fibrin-Specific Nuclear Probe to Reduce LVAD Adverse EventsR42HL139342 · NHLBI · CAPELLA IMAGING, LLC · PI BLACKLEDGE, JAMES, LANZA, GREGORY M · 2017 to 2019
$1.6M
Targeted Nanoparticles of Bismuth Organo Complexes for Spectral CT Imaging of CorR42HL112518 · NHLBI · OCEAN NANOTECH, LLC · PI LANZA, GREGORY M, WANG, YONGQIANG ANDREW · 2012 to 2015
$1.4M
NCI NIH HHS R01 CA216840NCI NIH HHS U54 CA199092NHLBI NIH HHS R42 HL112518NHLBI NIH HHS R42 HL139342NINDS NIH HHS R01 NS059302
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Myocardial InfarctionExtracellular MatrixHumansInflammationMagnetic Resonance ImagingEditorialsmacrophagesmagnetic resonance imagingmicemyocardial infarction

Identifiers

PMID30571326
PMCPMC6385888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.